Market Cap 138.86B
Revenue (ttm) 24.57B
Net Income (ttm) 3.61B
EPS (ttm) N/A
PE Ratio 24.59
Forward PE 22.89
Profit Margin 14.71%
Debt to Equity Ratio 0.33
Volume 6,090,400
Avg Vol 4,888,490
Day's Range N/A - N/A
Shares Out 707.77M
Stochastic %K 94%
Beta 0.81
Analysts Strong Sell
Price Target $235.91

Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell cultu...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 202 828 0850
Fax: 202 828 0860
Address:
2200 Pennsylvania Avenue N.W., Suite 800W, Washington, United States
FibonacciTrader_
FibonacciTrader_ Jun. 27 at 10:03 PM
Rotation is doing exactly what it usually does late-cycle- money stops chasing momentum and starts hiding in defensives with visible cash flows. This week the tape flipped hard: $ABBV +17% | pharma leadership catching bid on defensive + yield rotation $MRK +13% | large-cap healthcare strength as risk appetite fades $JNJ +12% | classic safety trade back in favor $DHR +11% | life sciences tools seeing steady institutional demand $LLY +10% | still strong structurally, but now part of broader defensive bid Meanwhile semis are cooling as AI beta unwinds from stretched positioning. This isn’t “AI is dead” pricing. It’s capital rotating from narrative to stability. When healthcare leads and semis lag, the market is telling you one thing: risk is being reduced, not added
0 · Reply
WhaleTracker_
WhaleTracker_ Jun. 27 at 2:10 PM
This week’s tape rotation is pretty clear - AI and semis took a breather, while defensives quietly led. 1-week returns: $ABBV +17% (AbbVie) $MRK +13% (Merck) $JNJ +12% (Johnson & Johnson) $DHR +11% (Danaher) $LLY +10% (Eli Lilly) What stands out isn’t just performance, but leadership shifting into healthcare while high-beta growth cooled off. This kind of rotation usually says more about positioning stress than any single macro headline - when crowded trades unwind, capital doesn’t disappear, it just moves.
0 · Reply
11thestate
11thestate Jun. 26 at 2:50 PM
Imagine buying $DHR at its peak, only to watch it crash like this and then finding out there’s a way to get some money back. To all $DHR investors out there, we’ve got some important news: a $172.5 million investor settlement is now open for claims from shareholders who purchased shares between 2022 and 2023. The deadline is in three months, you can check if you’re eligible and claim your share: https://11th.com/cases/danaher-investor-settlement
0 · Reply
charlietodd
charlietodd Jun. 25 at 10:36 PM
TODAY'S BIGGEST BETS $NVDA $MU $DHR The 4 largest options bets on index names today: Those MU puts down $3,000,000.00 Crazy bet on basically weeklies 1. $18.06M hit the Jan 21 '28 $200 NVDA puts at 9:29 AM ET while NVDA was near $194.47 — ~4,548 contracts at $39.71, day volume 4,660 vs OI 21,351, latest option mark $38.50 (-3% vs entry). 2. $7.42M hit the Jun 17 '27 $205 NVDA calls (sweep) at 10:08 AM ET while NVDA was near $195.97 — ~2,219 contracts at $33.45, day volume 2,281 vs OI 17,218, latest option mark $32.50 (-3% vs entry). 3. $6.45M hit the Jul 2 '26 $1150 MU puts (sweep, mostly new positioning) at 9:06 AM ET while MU was near $1147.37 — ~949 contracts at $68.00, day volume 1,266 vs OI 305, latest option mark $40.00 (-41% vs entry). 4. $6.23M hit the Sep 18 '26 $185 DHR calls at 9:16 AM ET while DHR was near $196.06 — ~3,250 contracts at $19.17, day volume 3,251 vs OI 3,796, latest option mark $18.50 (-3% vs entry).
1 · Reply
parcha
parcha Jun. 25 at 8:13 PM
https://youtube.com/watch?v=uaDtxF-IKqY&is=alcSIj3Ce5ewCDx_ $JPM $DHR $MRK
0 · Reply
AlphaFrontier
AlphaFrontier Jun. 24 at 10:18 PM
$DHR ripped 5.7% to around $189, an outsized move at nearly 3x its typical daily range. After a steady drawdown, this looks more like volatility expansion than a clean trend reversal. Still sitting ~22% below its 52-week high, so overhead supply is very real. The key is whether buyers can build acceptance here or if this fades into another relief bounce.
0 · Reply
OnlyFibs
OnlyFibs Jun. 24 at 7:06 PM
$DHR continues to transform its portfolio, moving aggressively toward high-margin diagnostics and life science tools. With the Masimo acquisition slated for 2H 2026 and margins expanding toward 23%, the operational leverage is clear. However, the market is cautious about the "strategic fit" of recent M&A. Patience is the edge while the bioprocessing cycle converts into sustained revenue growth. 💰 #hovdid 🐂 Bull Level: Sustain momentum above $180.00 to maintain the recovery trend. 🐻 Bear Level: Watching $175.00 as the primary pivot—if it fails, the technical consolidation could deepen toward the $160 support zone. #DHR #SmartMoney #Healthcare #Trading #hovdid
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 24 at 6:21 PM
$DHR Current Stock Price: $188.95 Contracts to trade: $190.0 DHR Jun 26 2026 Call Entry: $0.90 Exit: $1.32 ROI: 47% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DosGatos
DosGatos Jun. 22 at 1:06 PM
$DHR That’s It! DHR exec mgmt you are formally being put on a PIP!!
1 · Reply
SuperGreenToday
SuperGreenToday Jun. 22 at 10:46 AM
$DHR Share Price: $177.16 Contract Selected: Jul 17, 2026 $175 Calls Buy Zone: $6.20 – $7.65 Target Zone: $10.59 – $12.94 Potential Upside: 61% ROI Time to Expiration: 24 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Latest News on DHR
The Big 3: JPM, DHR, MRK

Jun 25, 2026, 1:00 PM EDT - 3 days ago

The Big 3: JPM, DHR, MRK

JPM MRK


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 11 days ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


Danaher initiated with a Neutral at Piper Sandler

2026-06-11T09:58:08.000Z - 18 days ago

Danaher initiated with a Neutral at Piper Sandler


Danaher completes acquisition of Masimo

2026-06-10T13:00:41.000Z - 18 days ago

Danaher completes acquisition of Masimo

MASI


Danaher Completes Acquisition of Masimo Corporation

Jun 10, 2026, 8:55 AM EDT - 18 days ago

Danaher Completes Acquisition of Masimo Corporation


Sirius XM Holdings Set to Join S&P MidCap 400

Jun 8, 2026, 6:09 PM EDT - 20 days ago

Sirius XM Holdings Set to Join S&P MidCap 400

SPGI


Sirius XM to replace Masimo in S&P 400 at open on 6/11

2026-06-08T21:20:13.000Z - 20 days ago

Sirius XM to replace Masimo in S&P 400 at open on 6/11

MASI SIRI


Danaher price target lowered to $230 from $270 at HSBC

2026-06-03T09:35:19.000Z - 26 days ago

Danaher price target lowered to $230 from $270 at HSBC


Danaher initiated with a Buy at DZ Bank

2026-06-03T08:55:09.000Z - 26 days ago

Danaher initiated with a Buy at DZ Bank


Danaher assumed with Peer Perform at Wolfe Research

2026-06-01T20:44:26.000Z - 27 days ago

Danaher assumed with Peer Perform at Wolfe Research

MASI TMO


Danaher resumed with a Buy at Citi

2026-05-27T10:31:11.000Z - 4 weeks ago

Danaher resumed with a Buy at Citi


Danaher resumed with an Outperform at RBC Capital

2026-05-14T20:49:09.000Z - 6 weeks ago

Danaher resumed with an Outperform at RBC Capital


Danaher Announces Quarterly Dividend

May 5, 2026, 4:30 PM EDT - 7 weeks ago

Danaher Announces Quarterly Dividend


Danaher Transcript: AGM 2026

May 5, 2026, 3:00 PM EDT - 7 weeks ago

Danaher Transcript: AGM 2026


Masimo shareholders approve acquisition by Danaher

2026-05-04T13:40:51.000Z - 7 weeks ago

Masimo shareholders approve acquisition by Danaher

MASI


Masimo Shareholders Approve Acquisition by Danaher

May 4, 2026, 9:00 AM EDT - 7 weeks ago

Masimo Shareholders Approve Acquisition by Danaher

MASI


Agilent appoints Michael Buckner as CLO

2026-05-04T12:32:30.000Z - 7 weeks ago

Agilent appoints Michael Buckner as CLO

A


Danaher price target lowered to $250 from $270 at UBS

2026-04-22T13:48:48.000Z - 2 months ago

Danaher price target lowered to $250 from $270 at UBS


Danaher price target lowered to $245 from $249 at Baird

2026-04-22T11:24:15.000Z - 2 months ago

Danaher price target lowered to $245 from $249 at Baird


Danaher price target lowered to $235 from $275 at Guggenheim

2026-04-22T11:18:47.000Z - 2 months ago

Danaher price target lowered to $235 from $275 at Guggenheim


Danaher price target raised to $245 from $240 at Jefferies

2026-04-21T18:11:29.000Z - 2 months ago

Danaher price target raised to $245 from $240 at Jefferies


Danaher Earnings Call Transcript: Q1 2026

Apr 21, 2026, 8:00 AM EDT - 2 months ago

Danaher Earnings Call Transcript: Q1 2026


Danaher Earnings release: Q1 2026

Apr 21, 2026, 8:00 AM EDT - 2 months ago

Danaher Earnings release: Q1 2026


Danaher Quarterly report: Q1 2026

Apr 21, 2026, 8:00 AM EDT - 2 months ago

Danaher Quarterly report: Q1 2026


Danaher Slides: Q1 2026

Apr 21, 2026, 8:00 AM EDT - 2 months ago

Danaher Slides: Q1 2026


Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains

Apr 21, 2026, 7:33 AM EDT - 2 months ago

Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains


Danaher Reports First Quarter 2026 Results

Apr 21, 2026, 6:00 AM EDT - 2 months ago

Danaher Reports First Quarter 2026 Results


Danaher Proxy statement: Proxy filing

Mar 25, 2026, 8:00 AM EDT - 3 months ago

Danaher Proxy statement: Proxy filing


Danaher Proxy statement: Proxy filing

Mar 25, 2026, 8:00 AM EDT - 3 months ago

Danaher Proxy statement: Proxy filing


Danaher Schedules First Quarter 2026 Earnings Conference Call

Mar 20, 2026, 4:15 PM EDT - 3 months ago

Danaher Schedules First Quarter 2026 Earnings Conference Call


Danaher Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 1:50 PM EST - 4 months ago

Danaher Transcript: TD Cowen 46th Annual Health Care Conference


Danaher Slides: Corporate presentation

Feb 26, 2026, 7:00 AM EST - 4 months ago

Danaher Slides: Corporate presentation


Danaher to Present at TD Cowen Health Care Conference

Feb 24, 2026, 4:05 PM EST - 4 months ago

Danaher to Present at TD Cowen Health Care Conference


Danaher to buy Masimo for $9.9 billion

Feb 17, 2026, 8:04 AM EST - 4 months ago

Danaher to buy Masimo for $9.9 billion

MASI


Masimo to be Acquired by Danaher for $180.00 Per Share

Feb 17, 2026, 8:02 AM EST - 4 months ago

Masimo to be Acquired by Danaher for $180.00 Per Share

MASI


Danaher To Acquire Masimo Corporation

Feb 17, 2026, 8:00 AM EST - 4 months ago

Danaher To Acquire Masimo Corporation

MASI


Danaher Strikes $10 Billion Deal for Masimo

Feb 17, 2026, 6:09 AM EST - 4 months ago

Danaher Strikes $10 Billion Deal for Masimo

MASI


Danaher Earnings Call Transcript: Q4 2025

Jan 28, 2026, 8:00 AM EST - 5 months ago

Danaher Earnings Call Transcript: Q4 2025


Danaher Annual report: Q4 2025

Jan 28, 2026, 8:00 AM EST - 5 months ago

Danaher Annual report: Q4 2025


Danaher Earnings release: Q4 2025

Jan 28, 2026, 8:00 AM EST - 5 months ago

Danaher Earnings release: Q4 2025


Danaher Slides: Q4 2025

Jan 28, 2026, 8:00 AM EST - 5 months ago

Danaher Slides: Q4 2025


Danaher Reports Fourth Quarter and Full Year 2025 Results

Jan 28, 2026, 6:00 AM EST - 5 months ago

Danaher Reports Fourth Quarter and Full Year 2025 Results


Danaher Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 5 months ago

Danaher Slides: 44th Annual J.P. Morgan Healthcare Conference


Danaher CEO to Comment on Financial Performance

Jan 12, 2026, 9:00 AM EST - 5 months ago

Danaher CEO to Comment on Financial Performance


The Big 3: BA, DHR, DG

Jan 8, 2026, 1:05 PM EST - 6 months ago

The Big 3: BA, DHR, DG

BA DG


Danaher Is Ready to Put Its Post-Covid Malaise Behind It

Jan 8, 2026, 8:00 AM EST - 6 months ago

Danaher Is Ready to Put Its Post-Covid Malaise Behind It


Danaher to Present at J.P. Morgan Healthcare Conference

Jan 5, 2026, 4:15 PM EST - 6 months ago

Danaher to Present at J.P. Morgan Healthcare Conference


Danaher Schedules Fourth Quarter 2025 Earnings Conference Call

Dec 17, 2025, 7:30 AM EST - 6 months ago

Danaher Schedules Fourth Quarter 2025 Earnings Conference Call


3 More Good Stocks to Invest In After Earnings

Nov 18, 2025, 4:29 PM EST - 7 months ago

3 More Good Stocks to Invest In After Earnings

FTNT LPLA


Danaher Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 6:00 AM EST - 7 months ago

Danaher Transcript: Jefferies London Healthcare Conference 2025


The Big 3: TMO, DHR, VLO

Nov 13, 2025, 12:50 PM EST - 8 months ago

The Big 3: TMO, DHR, VLO

TMO VLO


Danaher to Present at Jefferies Global Healthcare Conference

Nov 11, 2025, 4:15 PM EST - 8 months ago

Danaher to Present at Jefferies Global Healthcare Conference


Danaher Earnings Call Transcript: Q3 2025

Oct 21, 2025, 8:00 AM EDT - 8 months ago

Danaher Earnings Call Transcript: Q3 2025


Danaher Quarterly report: Q3 2025

Oct 21, 2025, 8:00 AM EDT - 8 months ago

Danaher Quarterly report: Q3 2025


Danaher Earnings release: Q3 2025

Oct 21, 2025, 8:00 AM EDT - 8 months ago

Danaher Earnings release: Q3 2025


Danaher Slides: Q3 2025

Oct 21, 2025, 8:00 AM EDT - 8 months ago

Danaher Slides: Q3 2025


Danaher Sales and Profit Rise on Bioprocessing Momentum

Oct 21, 2025, 6:23 AM EDT - 8 months ago

Danaher Sales and Profit Rise on Bioprocessing Momentum


Danaher Reports Third Quarter 2025 Results

Oct 21, 2025, 6:00 AM EDT - 8 months ago

Danaher Reports Third Quarter 2025 Results


Danaher Stock: Monopoly Margins, Discounted Price

Oct 15, 2025, 10:25 AM EDT - 9 months ago

Danaher Stock: Monopoly Margins, Discounted Price


4 Stocks That Aren't Too Hot to Buy Right Now

Oct 6, 2025, 2:45 PM EDT - 9 months ago

4 Stocks That Aren't Too Hot to Buy Right Now

EVRG KNTK PWR XLU


Danaher Schedules Third Quarter 2025 Earnings Conference Call

Sep 23, 2025, 4:15 PM EDT - 9 months ago

Danaher Schedules Third Quarter 2025 Earnings Conference Call


FibonacciTrader_
FibonacciTrader_ Jun. 27 at 10:03 PM
Rotation is doing exactly what it usually does late-cycle- money stops chasing momentum and starts hiding in defensives with visible cash flows. This week the tape flipped hard: $ABBV +17% | pharma leadership catching bid on defensive + yield rotation $MRK +13% | large-cap healthcare strength as risk appetite fades $JNJ +12% | classic safety trade back in favor $DHR +11% | life sciences tools seeing steady institutional demand $LLY +10% | still strong structurally, but now part of broader defensive bid Meanwhile semis are cooling as AI beta unwinds from stretched positioning. This isn’t “AI is dead” pricing. It’s capital rotating from narrative to stability. When healthcare leads and semis lag, the market is telling you one thing: risk is being reduced, not added
0 · Reply
WhaleTracker_
WhaleTracker_ Jun. 27 at 2:10 PM
This week’s tape rotation is pretty clear - AI and semis took a breather, while defensives quietly led. 1-week returns: $ABBV +17% (AbbVie) $MRK +13% (Merck) $JNJ +12% (Johnson & Johnson) $DHR +11% (Danaher) $LLY +10% (Eli Lilly) What stands out isn’t just performance, but leadership shifting into healthcare while high-beta growth cooled off. This kind of rotation usually says more about positioning stress than any single macro headline - when crowded trades unwind, capital doesn’t disappear, it just moves.
0 · Reply
11thestate
11thestate Jun. 26 at 2:50 PM
Imagine buying $DHR at its peak, only to watch it crash like this and then finding out there’s a way to get some money back. To all $DHR investors out there, we’ve got some important news: a $172.5 million investor settlement is now open for claims from shareholders who purchased shares between 2022 and 2023. The deadline is in three months, you can check if you’re eligible and claim your share: https://11th.com/cases/danaher-investor-settlement
0 · Reply
charlietodd
charlietodd Jun. 25 at 10:36 PM
TODAY'S BIGGEST BETS $NVDA $MU $DHR The 4 largest options bets on index names today: Those MU puts down $3,000,000.00 Crazy bet on basically weeklies 1. $18.06M hit the Jan 21 '28 $200 NVDA puts at 9:29 AM ET while NVDA was near $194.47 — ~4,548 contracts at $39.71, day volume 4,660 vs OI 21,351, latest option mark $38.50 (-3% vs entry). 2. $7.42M hit the Jun 17 '27 $205 NVDA calls (sweep) at 10:08 AM ET while NVDA was near $195.97 — ~2,219 contracts at $33.45, day volume 2,281 vs OI 17,218, latest option mark $32.50 (-3% vs entry). 3. $6.45M hit the Jul 2 '26 $1150 MU puts (sweep, mostly new positioning) at 9:06 AM ET while MU was near $1147.37 — ~949 contracts at $68.00, day volume 1,266 vs OI 305, latest option mark $40.00 (-41% vs entry). 4. $6.23M hit the Sep 18 '26 $185 DHR calls at 9:16 AM ET while DHR was near $196.06 — ~3,250 contracts at $19.17, day volume 3,251 vs OI 3,796, latest option mark $18.50 (-3% vs entry).
1 · Reply
parcha
parcha Jun. 25 at 8:13 PM
https://youtube.com/watch?v=uaDtxF-IKqY&is=alcSIj3Ce5ewCDx_ $JPM $DHR $MRK
0 · Reply
AlphaFrontier
AlphaFrontier Jun. 24 at 10:18 PM
$DHR ripped 5.7% to around $189, an outsized move at nearly 3x its typical daily range. After a steady drawdown, this looks more like volatility expansion than a clean trend reversal. Still sitting ~22% below its 52-week high, so overhead supply is very real. The key is whether buyers can build acceptance here or if this fades into another relief bounce.
0 · Reply
OnlyFibs
OnlyFibs Jun. 24 at 7:06 PM
$DHR continues to transform its portfolio, moving aggressively toward high-margin diagnostics and life science tools. With the Masimo acquisition slated for 2H 2026 and margins expanding toward 23%, the operational leverage is clear. However, the market is cautious about the "strategic fit" of recent M&A. Patience is the edge while the bioprocessing cycle converts into sustained revenue growth. 💰 #hovdid 🐂 Bull Level: Sustain momentum above $180.00 to maintain the recovery trend. 🐻 Bear Level: Watching $175.00 as the primary pivot—if it fails, the technical consolidation could deepen toward the $160 support zone. #DHR #SmartMoney #Healthcare #Trading #hovdid
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 24 at 6:21 PM
$DHR Current Stock Price: $188.95 Contracts to trade: $190.0 DHR Jun 26 2026 Call Entry: $0.90 Exit: $1.32 ROI: 47% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DosGatos
DosGatos Jun. 22 at 1:06 PM
$DHR That’s It! DHR exec mgmt you are formally being put on a PIP!!
1 · Reply
SuperGreenToday
SuperGreenToday Jun. 22 at 10:46 AM
$DHR Share Price: $177.16 Contract Selected: Jul 17, 2026 $175 Calls Buy Zone: $6.20 – $7.65 Target Zone: $10.59 – $12.94 Potential Upside: 61% ROI Time to Expiration: 24 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OptionRunners
OptionRunners Jun. 15 at 7:38 PM
$DHR large August call buyer into the close. Almost $2M in premium. Recent July spread opened as well.
1 · Reply
FlowSwingTrader
FlowSwingTrader Jun. 15 at 7:22 PM
$DHR Interesting flow... I'm in!
0 · Reply
11thestate
11thestate Jun. 12 at 2:47 PM
Did you own $DHR shares? A $172 million investor settlement has been reached. If you owned $DHR between January 27, 2022, and October 23, 2023, you may want to check whether you're eligible: https://11th.com/cases/danaher-investor-settlement
0 · Reply
TwongStocks
TwongStocks Jun. 10 at 1:58 PM
$DHR completes acquisition of $MASI https://www.prnewswire.com/news-releases/danaher-completes-acquisition-of-masimo-corporation-302796748.html MASI shareholders to receive $180 per share.
0 · Reply
notreload_ai
notreload_ai Jun. 9 at 12:07 PM
$SIRI stock rises as it joins the S&P MidCap 400 index on June 11, replacing $MASI (being bought by $DHR).
0 · Reply
Mergerbrief
Mergerbrief Jun. 9 at 12:00 PM
$DHR / $MASI - Expected Close
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 8 at 10:42 PM
SIRI Stock Surges 5% After-Hours On S&P MidCap 400 Inclusion $SIRI $MASI $DHR https://stocktwits.com/news/equity/markets/siri-stock-surges-after-hours-on-sandp-midcap-400-inclusion/cZ0vl5cR7bT
0 · Reply
OnlyFibs
OnlyFibs Jun. 8 at 12:51 AM
$DHR is in a tactical high-tension squeeze at the breakout zone. We’ve seen the stock absorb a mountain of overhead supply, and the current base-building is arguably the most durable setup we've seen this year. I’m ignoring the macro chatter and focusing strictly on the $260 support hold. When this technical base resolves, the upside will be sharp. Stay disciplined—we are at the goal line. ⚡ 🐂 Bull Level: Sustained momentum over $275.00 is the green light for the next leg higher. 🐻 Bear Level: If $260.00 gives way, brace for an immediate acceleration of selling pressure toward the recent base. #DHR #Stocks #Trading #Healthcare #hovdid
0 · Reply
11thestate
11thestate Jun. 2 at 2:42 PM
$DHR One of the largest new investor settlements this year just moved forward. The Danaher Corporation $172.5 million settlement has been approved by the court The settlement claims that Danaher misled investors about demand in its bioprocessing business after the COVID boom. As customers reduced orders and worked through excess inventory, the company repeatedly lowered its outlook, leading to several stock declines. If you bought $DHR between January 27, 2022 and October 23, 2023 now may be a good time to fill your claim: https://11th.com/cases/danaher-investor-settlement
0 · Reply
TalkMarkets
TalkMarkets May. 28 at 10:30 PM
Home Builders Could Drop 15% $TOL $ITB $SPY $DHR $TMO https://talkmarkets.com/article/home-builders-could-drop-15-1780007381
0 · Reply
cubie
cubie May. 28 at 7:26 PM
$A $DHR $TMO congrats bio equipment giddy bulls🫡😅
2 · Reply
11thestate
11thestate May. 22 at 2:08 PM
When we see a stock like this, we know how many damaged investors are out there. Believe it or not, there’s some good news. $DHR investors you might be surprised, but you actually have a chance to recover your losses. Don’t miss it: https://11th.com/cases/danaher-investor-settlement
0 · Reply